# Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)

> **NCT06012279** · PHASE4 · COMPLETED · sponsor: **Cairo University** · enrollment: 117 (actual)

## Conditions studied

- Acute Heart Failure

## Interventions

- **DRUG:** Dapagliflozin 10mg Tab

## Key facts

- **NCT ID:** NCT06012279
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-02-26
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06012279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06012279, "Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06012279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*